My next question is for Doctors Without Borders.
On May 31, Mr. Hamill, the chief of staff and vice-president of legal affairs for Innovative Medicines Canada, came before the committee. He said the TPP would not increase the cost of Canadian medicines, for the following reason:
Intellectual property protection does not drive the cost of new medicines. Besides, nothing in the TPP will prevent the Canadian federal, provincial and territorial governments from doing exactly what they do now....
How would you respond to that?